Understood, we will see if he meets his timeline. NP does a bad job managing expectations, as I have said. Each shareholder gets to decide for themselves. But he will be judged ultimately if he gets the deal done, drug approved, etc. So I will hold off until the final note is written. But to give a deadline and miss is bad, I understand any frustration from that, especially with trolls trying to attack, gives them strong support.

With TNBC, first patient, they did ctcs two weeks later, sounds like they got similar results as the mice model. I’m here until approval or bust, but with results like that, we are going to win in the end imo, what it will be there before I don’t know, but I’ve waited this long, I’m not going to stop now, when I think is is happening this close.